GSK-Pfizer deal wins New Zealand regulatory approval
MLex Summary: GlaxoSmithKline’s plan to acquire Pfizer’s consumer healthcare business won regulatory approval today in New Zealand after the country's competition regulator said it would not substantially lessen competition in any...To view the full article, register now.
Already a subscriber? Click here to view full article